Literature DB >> 1397119

Accumulation of crystallin in developing chicken lens.

T Inoue1, J Miyazaki, T Hirabayashi.   

Abstract

Separation and quantitation of crystallin subunits in embryonic and post-hatched chicken lens were carried out by two-dimensional gel electrophoresis and an image analysing system in order to elucidate detail in the accumulation process of each crystallin subunit in lens differentiation. Complete separation of the subunits was possible when 7 M urea was included in the second dimension gel of the electrophoresis. In particular, beta-crystallin could be separated into more than 24 spots on the gel. These experiments showed that delta-crystallin accumulated rapidly during early development up to more than 80% of total crystallins, while beta-crystallin accumulated quickly only after hatching. In contrast with the contents of beta- and delta-crystallins, alpha-crystallin content in total crystallins was kept at approximately 18% throughout lens development. Therefore, it was concluded that crystallins accumulated in several different ways. This suggests that different regulation mechanisms work on the accumulation of each crystallin subunit and that the subunit composition of lens proteins is specific to each state of lens development.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1397119     DOI: 10.1016/0014-4835(92)90085-7

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  2 in total

1.  Changes in protein profiles of guinea pig sclera during development of form deprivation myopia and recovery.

Authors:  Xiangtian Zhou; Juxiu Ye; Mark D P Willcox; Ruozhong Xie; Liqin Jiang; Runxia Lu; Jianzhen Shi; Yan Bai; Jia Qu
Journal:  Mol Vis       Date:  2010-10-27       Impact factor: 2.367

2.  Patterns of Crystallin Gene Expression in Differentiation State Specific Regions of the Embryonic Chicken Lens.

Authors:  Zhiwei Ma; Daniel Chauss; Joshua Disatham; Xiaodong Jiao; Lisa Ann Brennan; A Sue Menko; Marc Kantorow; J Fielding Hejtmancik
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-04-01       Impact factor: 4.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.